REN1 Antibody

What is REN antibody and what biological systems does it target?

REN antibodies are used in the immunodetection of renin protein. In humans, the canonical protein has a reported length of 406 amino acid residues and a mass of 45.1 kDa. Renin is a secreted protein belonging to the Peptidase A1 protein family, known to be involved with kidney development and male gonad development . Up to 2 different isoforms have been reported for this protein, and post-translational modifications including glycosylation have been described .

The REN marker can be specifically used to identify Juxtaglomerular Granular Cells in experimental contexts . Synonyms for this target antigen include HNFJ2, RTD, angiotensin-forming enzyme, angiotensinogenase, renin precursor, renal, and ADTKD4 .

What experimental applications are REN antibodies most suitable for?

REN antibodies have demonstrated utility across multiple research applications, with varying degrees of optimization required:

Over 90 citations in the literature describe the use of REN antibodies in research . For optimal results, each application requires specific protocol optimization including antibody concentration, incubation time, and appropriate controls.

How should researchers design proper controls when using REN antibodies?

Robust experimental design requires multiple control types:

• Positive Controls: Samples known to express renin (e.g., kidney tissue)

• Negative Controls: Tissues or cells known not to express the target protein

• Isotype Controls: Antibodies of the same isotype but different specificity, similar to how anti-Zika virus monoclonal antibody Z021 was used as an isotype control in other antibody research

• Secondary Antibody-Only Controls: To detect non-specific binding

For microscopy-based assays, similar control approaches used in SARS-CoV-2 research can be adapted, including blocking with 5% goat serum in PBS followed by appropriate primary and secondary antibody incubations .

What methodologies are available for characterizing antibody binding kinetics?

Biolayer interferometry (BLI) using instruments such as the Octet Red is the gold standard for determining antibody-antigen binding kinetics . The methodology involves:

• Biotinylating the target protein (concentration: ~5 μg/mL)

• Immobilizing onto streptavidin biosensors

• Measuring association with serially diluted antibodies (typical range: 500 nM to 7.8125 nM)

• Recording dissociation over time (typically 300 seconds)

• Analyzing data using a 1:1 binding model

For reference, high-affinity antibodies studied with this methodology showed KD values of (1.37×10⁻⁹ ± 3.53×10⁻¹¹) M, (5.29×10⁻⁹ ± 6.16×10⁻¹¹) M, and less than 10⁻¹² M , providing benchmarks for expected binding affinities.

How can epitope mapping be performed to characterize antibody-antigen interactions?

Epitope mapping is crucial for understanding antibody function. A systematic approach includes:

• Biolayer Interferometry "Classical Sandwich Assay":

  • Immerse protein A biosensor in buffer (30 seconds)

  • Capture first antibody (Ab1) at 40 μg/ml (10 minutes)

  • Establish baseline in buffer (30 seconds)

  • Block with IgG isotype control at 50 μg/ml (5 minutes)

  • Associate antigen at 100 μg/ml (5 minutes)

  • Re-establish baseline (30 seconds)

  • Associate second antibody (Ab2) at 40 μg/ml (5 minutes)

  • Analyze data with Fortebio Octet software

• Complementary Methods:

  • X-ray crystallography of antibody-antigen complexes

  • Hydrogen-deuterium exchange mass spectrometry

  • Peptide array scanning

These approaches provide structural insights into binding mechanisms that inform antibody engineering efforts.

What strategies can be employed for antibody sequencing, cloning, and expression?

The following methodological pipeline has proven effective for antibody development:

• Antibody Sequencing:

  • Extract RNA from single B cells

  • Reverse-transcribe using SuperScript III Reverse Transcriptase

  • Amplify variable IGH, IGL, and IGK genes by nested PCR

  • Perform Sanger sequencing and analyze with software like MacVector

• Cloning and Expression:

  • Use amplicons from first PCR as templates

  • Employ sequence- and ligation-independent cloning into antibody expression vectors

  • Co-transfect paired IgG heavy and light chain plasmids into 293F cells

  • Incubate at 37°C in humidified 8% CO₂ environment for five days

  • Purify using recombinant protein-A columns

• Validation:

  • Determine concentration via spectrophotometry

  • Verify binding via ELISA and BLI

This systematic approach ensures production of functional antibodies with defined specificity.

How should cross-reactivity testing be designed for antibodies with multiple species targets?

REN gene orthologs have been reported in mouse, rat, bovine, frog, chimpanzee and chicken species , necessitating careful cross-reactivity assessment:

• In silico analysis: Align protein sequences across species to identify conserved epitopes

• Experimental validation:

  • Western blot with lysates from multiple species

  • ELISA with recombinant proteins from different species

  • Immunohistochemistry on tissue sections from various organisms

• Optimization strategies:

  • Species-specific blocking reagents

  • Titration to determine optimal concentration for each species

  • Validation with genetic knockouts where available

This comprehensive approach prevents misinterpretation of results in cross-species studies.

What are the recommended protocols for ELISA using REN antibodies?

Based on antibody research methodologies, an optimized ELISA protocol would include:

• Plate Preparation:

  • Coat plates with capture antigen/antibody overnight at 4°C

  • Wash and block with appropriate buffer (typically 5% BSA or serum)

• Sample Preparation and Incubation:

  • Prepare dilution series (reference antibodies showed EC₅₀ values of 0.004-0.019 μg/mL)

  • Incubate samples at optimal temperature and duration

• Detection and Analysis:

  • Add detection reagents and substrate

  • Measure using appropriate instrumentation

  • Calculate EC₅₀ values using four-parameter logistic regression

This methodological approach enables quantitative analysis of antibody-antigen interactions with high sensitivity and reproducibility.

How can microscopy-based assays be optimized for REN antibody applications?

Drawing from established immunofluorescence protocols :

• Sample Preparation:

  • Fix cells with appropriate fixative (e.g., 7% formaldehyde)

  • Permeabilize with 0.1% Triton X-100 for 10 minutes if detecting intracellular targets

• Antibody Incubation:

  • Block with 5% goat serum in PBS

  • Apply primary antibody at optimized dilution

  • Incubate overnight at 4°C for optimal binding

• Detection:

  • Apply fluorophore-conjugated secondary antibody (e.g., AlexaFluor 594 at 1:2,000 dilution)

  • Counterstain nuclei with Hoechst 33342 (1:1,000)

• Imaging and Analysis:

  • Acquire images with appropriate microscopy setup

  • Analyze using software like ImageXpress or MetaXpress

This systematic approach ensures high-quality imaging data with minimal background and optimal signal-to-noise ratio.

What approaches for single B cell isolation can be adapted for developing novel REN antibodies?

Based on successful antibody isolation strategies :

• B Cell Isolation Methods:

  • RBD-specific single B cell sorting using flow cytometry (FACS)

  • Memory B cell enrichment prior to sorting

• Alternative Advanced Approaches:

  • Next-generation sequencing technologies for broader repertoire analysis

  • Proteomics approaches for antibody identification

  • Antibodyomics methods to identify thousands of somatic variants

• Analytical Framework:

  • Unbiased antibody repertoire sequencing

  • Phylogenetic analysis to reveal B cell maturation processes

  • Evolutionary pathway construction for isolated antibodies

These methodologies have successfully identified potent neutralizing antibodies and can be adapted for isolating high-affinity REN-specific antibodies .

How should researchers analyze antibody binding kinetics data?

For rigorous analysis of binding kinetics:

• Raw Data Processing:

  • Reference subtraction to remove background signal

  • Alignment of association start times

• Kinetic Modeling:

  • Apply 1:1 binding model as standard approach

  • Consider more complex models if data shows systematic deviations

  • Calculate association (ka), dissociation (kd), and equilibrium (KD) constants

• Quality Assessment:

  • Evaluate residual plots for systematic deviations

  • Perform replicate experiments to ensure reproducibility

  • Calculate confidence intervals using statistical approaches

This analytical framework ensures accurate determination of binding parameters critical for antibody characterization.

What statistical approaches should be used when evaluating antibody specificity and sensitivity?

Robust statistical analysis includes:

• For ELISA Data:

  • Four-parameter logistic regression for EC₅₀ determination

  • ANOVA with post-hoc tests for comparing conditions

  • Calculation of coefficient of variation for assessing precision

• For Binding Kinetics:

  • Bootstrap analysis for confidence intervals

  • Goodness-of-fit assessment using reduced chi-square values

  • Global fitting across multiple concentrations

• For Multiplex Data:

  • Principal component analysis for pattern identification

  • Hierarchical clustering for relationship mapping

  • False discovery rate correction (Benjamini-Hochberg algorithm) for multiple comparisons

What are common sources of variability in antibody experiments and how can they be addressed?

Several key factors affect reproducibility in antibody-based experiments:

Implementing a comprehensive quality control system that includes reference standards, detailed documentation, and regular proficiency testing significantly enhances reproducibility .

How can researchers optimize antibody concentration for different applications?

Systematic titration is essential for determining optimal antibody concentrations:

• For Western Blot:

  • Test dilution series (typically 1:500 to 1:5000)

  • Evaluate signal-to-noise ratio at each concentration

  • Select concentration that maximizes specific signal while minimizing background

• For Immunohistochemistry:

  • Prepare dilution series (typically 1:100 to 1:1000)

  • Test on positive control tissues

  • Assess staining intensity, specificity, and background

• For ELISA:

  • Perform checkerboard titration of capture and detection antibodies

  • Generate standard curves at each concentration

  • Select concentration that provides optimal dynamic range and sensitivity

This methodological approach ensures optimal performance across different experimental platforms.

What strategies can overcome non-specific binding in REN antibody applications?

Non-specific binding can be addressed through multiple approaches:

• Blocking Optimization:

  • Test different blocking agents (BSA, milk, normal serum)

  • Optimize blocking time and temperature

  • Consider adding detergents (0.05-0.1% Tween-20) to reduce hydrophobic interactions

• Antibody Purification:

  • Pre-absorb against tissues/cells lacking target protein

  • Consider affinity purification against specific antigens

  • Remove aggregated antibody via centrifugation

• Buffer Optimization:

  • Adjust salt concentration to reduce ionic interactions

  • Optimize pH for specific applications

  • Add carrier proteins to prevent non-specific adsorption

These methodological refinements significantly enhance signal specificity and experimental reproducibility.